期刊
JOURNAL OF BIOLOGICAL CHEMISTRY
卷 287, 期 30, 页码 25151-25162出版社
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M112.379339
关键词
-
资金
- National Institutes of Health [R21 DA027070-02S1, R21 DA026627]
- Men's and Women's Boards of the Barrow Neurological Foundation
Genome-wide studies have strongly associated a non-synonymous polymorphism (rs16969968) that changes the 398th amino acid in the nAChR alpha 5 subunit from aspartic acid to asparagine (D398N), with greater risk for increased nicotine consumption. We have used a pentameric concatemer approach to express defined and consistent populations of alpha 3 beta 4 alpha 5 nAChR in Xenopus oocytes. alpha 5(Asn-398; risk) variant incorporation reduces ACh-evoked function compared with inclusion of the common alpha 5(Asp-398) variant without altering agonist or antagonist potencies. Unlinked alpha 3, beta 4, and alpha 5 subunits assemble to form a uniform nAChR population with pharmacological properties matching those of concatemeric alpha 3 beta 4* nAChRs. alpha 5 subunit incorporation reduces alpha 3 beta 4* nAChR function after coinjection with unlinked alpha 3 and beta 4 subunits but increases that of alpha 3 beta 4 alpha 5 versus alpha 3 beta 4-only concatemers. alpha 5 subunit incorporation into alpha 3 beta 4* nAChR also alters the relative efficacies of competitive agonists and changes the potency of the non-competitive antagonist mecamylamine. Additional observations indicated that in the absence of alpha 5 subunits, free alpha 3 and beta 4 subunits form at least two further subtypes. The pharmacological profiles of these free subunit alpha 3 beta 4-only subtypes are dissimilar both to each other and to those of alpha 3 beta 4 alpha 5 nAChR. The alpha 5 variant-induced change in alpha 3 beta 4 alpha 5 nAChR function may underlie some of the phenotypic changes associated with this polymorphism.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据